Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02949245 · ClinicalTrials.gov registry record
Neurologic Complications in Spinal Deformity Surgery - Extension
A clinical trial, sponsored by AO Foundation, AO Spine.
- Completed
- Registry status
- 77
- Enrollment target
NCT02949245: Completed study, sponsored by AO Foundation, AO Spine.
NCT02949245 is a clinical trial that has completed, run by AO Foundation, AO Spine. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02949245 has completed, sponsored by AO Foundation, AO Spine.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
Study Summary
272 subjects with "high risk" adult spinal deformity requiring surgical correction were enrolled in the previous prospective multi-center international Scoli-RISK-1 study. "High risk" patients were defined by either their diagnoses and/or the type of surgical intervention as listed in the inclusion criteria. Neurological complications in the form of new motor and sensory deficits were monitored prospectively in all patients at hospital discharge, at 6 weeks (± 2 weeks), 6 months (± 2 months) and 24 months (± 2 months) after the surgery. The relationship to the surgical intervention was assessed in all new deficits. Regression analyses were used to evaluate the association between patient demographics, co-morbidities, treatment history, spinal deformity characteristics, surgical characteristics, non-neurologic complications and pre-surgical status to occurrence of a neurologic deficit after surgery. All enrolled Scoli-RISK-1 participants will be re-consented and asked to return for a 5 year FU visit.
Primary Outcome
Rate of treatment-related neurological complications determined by the Clinical Endpoint Committee (CEC) whether complications are of neurological nature or not.
Interventions
- PROCEDURE Interventions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2017-08-17 |
| Est. Completion | 2019-12-28 |
What the finished NCT02949245 record still lists
NCT02949245 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Interventions is the first listed.
NCT02949245 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02949245 about?
NCT02949245 is a clinical study titled "Neurologic Complications in Spinal Deformity Surgery - Extension". 272 subjects with "high risk" adult spinal deformity requiring surgical correction were enrolled in the previous prospective multi-center international Scoli-RISK-1 study. "High risk" patients were defined by either their diagnoses and/or the type of surgical intervention as listed in the inclusion ...
What is the current status of trial NCT02949245?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2017-08-17. Estimated completion is 2019-12-28.
What interventions are being tested in trial NCT02949245?
The interventions under investigation include: Interventions (PROCEDURE).
Who is sponsoring clinical trial NCT02949245?
This trial is sponsored by AO Foundation, AO Spine, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI